Literature DB >> 30803937

Interatrial shunting for heart failure: current evidence and future perspectives.

Leonardo Guimaraes1, Joanne Lindenfeld, Julio Sandoval, Antoni Bayés-Genis, Mathieu Bernier, Steeve Provencher, Josep Rodés-Cabau.   

Abstract

The creation of an interatrial shunt in order to decompress the right or left atrium in patients with right and left ventricular failure, respectively, has been used as an alternative therapy to improve symptoms and clinical outcomes in patients with pulmonary hypertension-right heart failure and left heart failure refractory to optimal medical therapy. If ongoing randomised clinical trials further substantiate these beneficial effects in patients with chronic HF, interatrial shunting will represent an important new approach for treating this population.

Entities:  

Mesh:

Year:  2019        PMID: 30803937     DOI: 10.4244/EIJ-D-18-01211

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  1 in total

1.  Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device.

Authors:  Xiaoke Shang; Mei Liu; Yucheng Zhong; Xueli Wang; Song Chen; Xiaojuan Fu; Ming Sun; Mingxing Xie; Yuhe Ke; Ying Guan; Changdong Zhang; Nianguo Dong
Journal:  ESC Heart Fail       Date:  2022-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.